Fortis Healthcare faces GST demands totaling ₹21.7 Crores for FY21-23
Fortis Healthcare received GST orders confirming demands totaling ₹21.70 crore (₹4.78 crore for FY21, ₹8.50 crore for FY22, ₹8.12 crore for FY23) including interest and penalties. Show cause notices for the remaining amounts were dropped.
The total confirmed demand of ₹21.70 crore is a significant amount, but given the company's overall revenue and profitability, the immediate impact is assessed as medium. However, the ongoing nature of tax litigation can pose a risk.
The company has received confirmed GST demands including penalties and interest, which represents a financial liability and potential negative impact on profitability.
Fortis Healthcare Limited has disclosed its receipt of Goods and Services Tax (GST) orders impacting financial years 2020-21, 2021-22, and 2022-23. The company received show cause notices from the State Tax Officer, Chengalpattu Intelligence Division, Tamil Nadu, for amounts including penalties.
For FY 2020-21, the GST authority has confirmed demands of ₹478.08 lakhs, which includes interest and penalty of ₹142.02 lakhs and ₹168.03 lakhs respectively. For FY 2021-22, confirmed demands amount to ₹850.00 lakhs, with interest and penalty totaling ₹212.16 lakhs and ₹318.92 lakhs. For FY 2022-23, the confirmed demands are ₹811.53 lakhs, including interest and penalty of ₹158.58 lakhs and ₹326.47 lakhs.
The show cause notices related to the balance amounts have been dropped by the GST authority. The events occurred on December 29, 2025, at 5:46 PM for FY 2020-21, December 29, 2025, at 5:53 PM for FY 2021-22, and December 30, 2025, at 4:38 PM for FY 2022-23. Satyendra Chauhan, Company Secretary & Compliance Officer, made the disclosure.
What to do with a filing like this
Fortis Healthcare Limited filed this with the NSE as a statutory disclosure, categorised under litigation updates. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Fortis Healthcare Limited. Read the original for the full detail.